Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Monitoring peripheral blood CD4(+) intracellular adenosine triphosphate concentration in patients with psoriasis treated with fumaric acid esters.

Gambichler T, Scola N, Rotterdam S, Höxtermann S, Haghikia A, Faissner S, Kreuter A, Bechara FG, Altmeyer P, Chan A.

Acta Derm Venereol. 2012 Jul;92(4):364-6. doi: 10.2340/00015555-1266. No abstract available.

PMID:
22294455
[PubMed - indexed for MEDLINE]
Free Article
2.

Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis.

Höxtermann S, Nüchel C, Altmeyer P.

Dermatology. 1998;196(2):223-30.

PMID:
9568412
[PubMed - indexed for MEDLINE]
3.

Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients.

Kokelj F, Plozzer C, Avian A, Trevisan G.

Acta Dermatovenerol Croat. 2009;17(3):170-5.

PMID:
19818215
[PubMed - indexed for MEDLINE]
4.

Significance of CD4 T-cell adenosine triphosphate levels monitoring in elderly renal transplant recipients.

Wu Z, Zhou H, Yang S, Cai J, Wang Q, Liao L, Tan J.

Transplant Proc. 2012 Dec;44(10):2986-91. doi: 10.1016/j.transproceed.2012.05.083. Epub 2012 Nov 1.

PMID:
23195011
[PubMed - indexed for MEDLINE]
5.

Interleukin 4 or cytokine antagonists? Time to change the search for novel psoriasis therapies.

Röcken M.

Dermatology. 2010 Aug;221(1):27-9. doi: 10.1159/000314153. Epub 2010 Jun 26. No abstract available.

PMID:
20587989
[PubMed - indexed for MEDLINE]
Free Article
6.

Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in psoriasis.

Bacharach-Buhles M, Pawlak FM, Matthes U, Joshi RK, Altmeyer P.

Acta Derm Venereol Suppl (Stockh). 1994;186:79-82.

PMID:
7915483
[PubMed - indexed for MEDLINE]
7.

Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.

Balasubramaniam P, Stevenson O, Berth-Jones J.

Br J Dermatol. 2004 Apr;150(4):741-6.

PMID:
15099371
[PubMed - indexed for MEDLINE]
8.

Fumaric acid esters: an alternative systemic treatment for psoriasis.

Ameen M, Russell-Jones R.

Clin Exp Dermatol. 1999 Sep;24(5):361-4.

PMID:
10564321
[PubMed - indexed for MEDLINE]
9.

Fumaric acid esters for severe psoriasis: the Leicestershire experience.

Sladden MJ, Osborne JE, Hutchinson PE.

Br J Dermatol. 2006 Oct;155(4):843-4. No abstract available.

PMID:
16965442
[PubMed - indexed for MEDLINE]
10.

Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.

Harries MJ, Chalmers RJ, Griffiths CE.

Br J Dermatol. 2005 Sep;153(3):549-51.

PMID:
16120141
[PubMed - indexed for MEDLINE]
11.

[Vision disorders in therapy with fumaric acid esters?].

Wirth G.

Hautarzt. 2003 Mar;54(3):301; discussion 301. German. No abstract available.

PMID:
12723574
[PubMed - indexed for MEDLINE]
12.

Resolution of psoriatic skin lesions with fludarabine.

Karadoğan I, Akça S, Undar L.

Am J Med. 1999 Sep;107(3):300-1. No abstract available.

PMID:
10492335
[PubMed - indexed for MEDLINE]
13.

Fumaric acid esters in the management of severe psoriasis.

Brewer L, Rogers S.

Clin Exp Dermatol. 2007 May;32(3):246-9. Epub 2007 Mar 14.

PMID:
17362235
[PubMed - indexed for MEDLINE]
14.

Fumaric acid esters in psoriasis and multiple sclerosis.

Zecca C, Caporro M, Adami M, Mainetti C, Gobbi C.

Clin Exp Dermatol. 2014 Jun;39(4):488-91. doi: 10.1111/ced.12326. Epub 2014 Apr 30.

PMID:
24779791
[PubMed - indexed for MEDLINE]
15.

Fumaric acid esters in psoriasis.

Fika Z, Williams RE, Williamson DJ.

Br J Dermatol. 2006 Mar;154(3):567-8. No abstract available.

PMID:
16445802
[PubMed - indexed for MEDLINE]
16.

Use of fumaric acid esters in psoriasis.

Roll A, Reich K, Boer A.

Indian J Dermatol Venereol Leprol. 2007 Mar-Apr;73(2):133-7.

PMID:
17456929
[PubMed - indexed for MEDLINE]
Free Article
17.

Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experience.

Heelan K, Markham T.

Clin Exp Dermatol. 2012 Oct;37(7):793-5. doi: 10.1111/j.1365-2230.2012.04351.x. Epub 2012 Apr 30. No abstract available.

PMID:
22548419
[PubMed - indexed for MEDLINE]
18.

CD4+ CD25+ T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement.

Richetta AG, Mattozzi C, Salvi M, Giancristoforo S, D'epiro S, Milana B, Carboni V, Zampetti M, Calvieri S, Morrone S.

Eur J Dermatol. 2011 May-Jun;21(3):344-8. doi: 10.1684/ejd.2011.1362.

PMID:
21680285
[PubMed - indexed for MEDLINE]
19.

Fumaric acid esters, their place in the treatment of psoriasis.

Ormerod AD, Mrowietz U.

Br J Dermatol. 2004 Apr;150(4):630-2. Review. No abstract available.

PMID:
15099356
[PubMed - indexed for MEDLINE]
20.

Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial.

Fallah Arani S, Neumann H, Hop WC, Thio HB.

Br J Dermatol. 2011 Apr;164(4):855-61. doi: 10.1111/j.1365-2133.2010.10195.x. Epub 2011 Mar 21.

PMID:
21175564
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk